Clinical challenges in the management of osteoporosis

Código QR

Clinical challenges in the management of osteoporosis

Sheryl F Vondracek1, Paul Minne2, Michael T McDermott31Department of Clinical Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA; 2Amgen Medical Affairs, Denver, CO, USA; 3Director of the Endocrine and Diabetes Practice, Department of Medicine, University of Color...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sheryl F Vondracek, Paul Minne, Michael T McDermott
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/454f0996718f4dfe975e19c7a13da0c9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Diagnosis and management of osteoporosis in the older senior
por: Sheryl F Vondracek, et al.
Publicado: (2009)

Teriparatide in the management of osteoporosis
por: Donald Bodenner, et al.
Publicado: (2008)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Oliver Bock, et al.
Publicado: (2008)

Osteoporosis screening and risk management
por: Consuelo H Wilkins
Publicado: (2007)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
por: John Sunyecz
Publicado: (2008)

Osteoporosis in the aging male: Treatment options
por: Stephen P Tuck, et al.
Publicado: (2008)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
por: Raja Bobba, et al.
Publicado: (2007)

Editorial: Challenges facing age-management/longevity medicine ||Free Paper||
por: Richard F Walker
Publicado: (2007)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Philip Sambrook
Publicado: (2007)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
por: María J Moro-Álvarez, et al.
Publicado: (2008)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
por: Esteban Jódar-Gimeno
Publicado: (2007)

The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
por: Silvia Migliaccio, et al.
Publicado: (2007)

Heart failure and cognitive impairment: Challenges and opportunities
por: George A Heckman, et al.
Publicado: (2007)

Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Paul K Piper Jr, et al.
Publicado: (2009)

Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update
por: Nagy EE, et al.
Publicado: (2020)

Pharmacological pain management in the elderly patient
por: Gary McCleane
Publicado: (2008)

The challenge of supporting care for dementia in primary care
por: Malaz Boustani, et al.
Publicado: (2008)

Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Travis M Falconer, et al.
Publicado: (2008)

Polypharmacy: Misleading, but manageable
por: Reamer L Bushardt, et al.
Publicado: (2008)

Pharmacologic management of overactive bladder
por: Sum Lam, et al.
Publicado: (2007)

The management of hemophilia in elderly patients
por: Massimo Franchini, et al.
Publicado: (2007)

Postoperative delirium in the elderly: diagnosis and management
por: Thomas N Robinson, et al.
Publicado: (2008)

Management of the behavioral and psychological symptoms of dementia
por: Elizabeth C Hersch, et al.
Publicado: (2008)

Activity and potential role of licofelone in the management of osteoarthritis
por: Arrigo FG Cicero, et al.
Publicado: (2007)

Long-term management of GERD in the elderly with pantoprazole
por: Carlo Calabrese, et al.
Publicado: (2007)

Management of chronic pain in the elderly: focus on transdermal buprenorphine
por: Nalini Vadivelu, et al.
Publicado: (2008)

Hyaluronic acid gel fillers in the management of facial aging
por: Fredric S Brandt, et al.
Publicado: (2008)

Update on the use of dutasteride in the management of benign prostatic hypertrophy
por: Joe Miller, et al.
Publicado: (2007)

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
por: Peker N, et al.
Publicado: (2018)

Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence
por: Maria Garefalakis, et al.
Publicado: (2008)

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole
por: Tang RS, et al.
Publicado: (2013)

Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas KM, et al.
Publicado: (2014)

Pharmacological treatment of osteoporosis in the oldest old
por: Vandenbroucke A, et al.
Publicado: (2017)

Factors contributing to fecal incontinence in older people and outcome of routine management in home, hospital and nursing home settings
por: Asangaedem Akpan, et al.
Publicado: (2007)

A non-pharmacological intervention to manage behavioral and psychological symptoms of dementia and reduce caregiver distress: Design and methods of project ACT3
por: Laura N Gitlin, et al.
Publicado: (2008)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011)

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives
por: Lin X, et al.
Publicado: (2015)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Tahir Masud, et al.
Publicado: (2009)

Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: Experimental and clinical evidence  ||FREE PAPER||
por: Marco Romanelli, et al.
Publicado: (2008)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009)